Patents by Inventor Mark Brister

Mark Brister has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8478377
    Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
    Type: Grant
    Filed: November 7, 2008
    Date of Patent: July 2, 2013
    Assignee: Dexcom, Inc.
    Inventors: Mohammad Ali Shariati, Ying Li, Apurv Ullas Kamath, Peter C. Simpson, Richard C. Yang, Mark Brister
  • Patent number: 8457708
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: December 5, 2008
    Date of Patent: June 4, 2013
    Assignee: DexCom, Inc.
    Inventors: Mark Brister, Paul V. Neale, James Patrick Thrower, Daniel S. Kline, Daniel Shawn Codd, Sean Saint, Steve Masterson
  • Patent number: 8449464
    Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
    Type: Grant
    Filed: November 7, 2008
    Date of Patent: May 28, 2013
    Assignee: Dexcom, Inc.
    Inventors: Peter C. Simpson, Michael J. Estes, Paul V. Neale, Robert Boock, Jacob S. Leach, Richard C. Yang, Mark Brister
  • Patent number: 8452368
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: January 14, 2009
    Date of Patent: May 28, 2013
    Assignee: DexCom, Inc.
    Inventors: Mark Brister, Daniel Kline, Steve Masterson, Sean Saint
  • Patent number: 8447376
    Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
    Type: Grant
    Filed: November 7, 2008
    Date of Patent: May 21, 2013
    Assignee: Dexcom, Inc.
    Inventors: Mohammad Ali Shariati, Ying Li, Apurv Ullas Kamath, Peter C. Simpson, Richard C. Yang, Mark Brister
  • Patent number: 8435286
    Abstract: The stent with an intermittent coating of the present invention provides a coating having a plurality of discrete coating sections disposed on a stent, i.e., an intermittent coating. The individual coating sections can contain different drugs or therapeutic agents, can be made of different polymers, can be made with different solvents, or combinations thereof. The coating sections can be applied in patterns such as ring patterns, striped patterns, spotted patterns, or dot matrix patterns. In one embodiment, the regions can be large relative to the stent, such as a ring pattern including one therapeutic agent in the radial regions at the ends of a stent and a different therapeutic agent in the radial region in the middle. In another embodiment, the regions can be small relative to the stent, such as a dot matrix pattern with each grid region being a small point.
    Type: Grant
    Filed: October 14, 2003
    Date of Patent: May 7, 2013
    Assignee: Medtronic Vascular, Inc.
    Inventor: Mark Brister
  • Patent number: 8425416
    Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
    Type: Grant
    Filed: March 25, 2008
    Date of Patent: April 23, 2013
    Assignee: Dexcom, Inc.
    Inventors: Mark Brister, Peter C. Simpson, Apurv Ullas Kamath, Jacob S. Leach, Vance Swanson, Sean Saint, John Nolting
  • Patent number: 8423114
    Abstract: Disclosed herein are systems and methods for a continuous analyte sensor, such as a continuous glucose sensor. One such system utilizes first and second working electrodes to measure additional analyte or non-analyte related signal. Such measurements may provide a background and/or sensitivity measurement(s) for use in processing sensor data and may be used to trigger events such as digital filtering of data or suspending display of data.
    Type: Grant
    Filed: October 1, 2007
    Date of Patent: April 16, 2013
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, Mark Brister, Matthew Wightlin, Jack Pryor
  • Patent number: 8396528
    Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
    Type: Grant
    Filed: March 25, 2008
    Date of Patent: March 12, 2013
    Assignee: DEXCOM, Inc.
    Inventors: Apurv Ullas Kamath, Peter C. Simpson, Mark Brister
  • Patent number: 8364230
    Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
    Type: Grant
    Filed: March 25, 2008
    Date of Patent: January 29, 2013
    Assignee: Dexcom, Inc.
    Inventors: Peter C. Simpson, Mark Brister, Jacob S. Leach
  • Patent number: 8364231
    Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
    Type: Grant
    Filed: March 25, 2008
    Date of Patent: January 29, 2013
    Assignee: Dexcom, Inc.
    Inventors: Apurv Ullas Kamath, Jacob S. Leach, Ying Li, Daiting Rong, Sean Saint, Peter C. Simpson, Mark Brister
  • Patent number: 8364229
    Abstract: Systems and methods of use involving sensors having a signal-to-noise ratio that is substantially unaffected by non-constant noise are provided for continuous analyte measurement in a host. In some embodiments, a continuous analyte measurement system is configured to be wholly, transcutaneously, intravascularly or extracorporeally implanted.
    Type: Grant
    Filed: May 18, 2007
    Date of Patent: January 29, 2013
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, Robert Boock, James R. Petisce, Mark Brister, Monica A. Rixman, Kum Ming Woo, Lisa Nguyen, Seth R. Brunner, Arthur Chee, Melissa A. Nicholas, Matthew Wightlin, Jack Pryor, Dubravka Markovic
  • Publication number: 20130012798
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: September 14, 2012
    Publication date: January 10, 2013
    Applicant: DexCom, Inc.
    Inventors: Mark Brister, Daniel Kline, Steve Masterson, Sean Saint
  • Patent number: 8321149
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: June 29, 2011
    Date of Patent: November 27, 2012
    Assignee: DexCom, Inc.
    Inventors: James H. Brauker, Apurv Ullas Kamath, Paul Goode, Mark Brister
  • Patent number: 8313434
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host and associated methods of manufacture. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host and associated methods of manufacture.
    Type: Grant
    Filed: March 1, 2007
    Date of Patent: November 20, 2012
    Assignee: DexCom, Inc.
    Inventors: Mark Brister, Daniel S. Kline, Steve Masterson, Sean Saint
  • Patent number: 8311749
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: May 26, 2011
    Date of Patent: November 13, 2012
    Assignee: DexCom, Inc.
    Inventors: James H. Brauker, Apurv Ullas Kamath, Paul Goode, Mark Brister
  • Publication number: 20120283543
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: July 13, 2012
    Publication date: November 8, 2012
    Applicant: DexCom, Inc
    Inventors: James H. Brauker, Apurv U. Kamath, Paul V. Goode, Mark Brister
  • Publication number: 20120277562
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: July 12, 2012
    Publication date: November 1, 2012
    Applicant: DexCom, Inc.
    Inventors: Mark Brister, Paul V. Neale, Sean Saint, James R. Petisce, Thomas F. McGee, Daniel Shawn Codd, David Michael Petersen, Daniel S. Kline
  • Patent number: 8298142
    Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
    Type: Grant
    Filed: November 7, 2008
    Date of Patent: October 30, 2012
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, Michael J. Estes, Paul V. Neale, Robert Boock, Jacob S. Leach, Richard C. Yang, Mark Brister
  • Patent number: 8287453
    Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
    Type: Grant
    Filed: November 7, 2008
    Date of Patent: October 16, 2012
    Assignee: DexCom, Inc.
    Inventors: Ying Li, Apurv Ullas Kamath, Mark Brister